FOLH1 and posterior cortical atrophy: Interestingly, DUPA, a synthetic urea-based ligand, can bind to PSMA with nanomolar affinity, saturating the receptor quickly [90], suggesting DUPA could be an ideal ligand for conjugated miR-34a therapeutic to target PCa.